Business & Consumer Services » Business Services | Syngene International Ltd.

Syngene International Ltd. | Cash Flow

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,566
2,035
2,408
2,873
3,054
Depreciation, Depletion & Amortization
656
814
973
1,143
1,314
Other Funds
-
40
22
21
48
Funds from Operations
1,792
2,365
3,384
3,989
4,688
Changes in Working Capital
1,292
2,158
255
369
266
Net Operating Cash Flow
3,084
207
3,129
4,358
4,422
Capital Expenditures
998
2,039
2,946
3,064
3,637
Sale of Fixed Assets & Businesses
28
-
2
-
-
Purchase/Sale of Investments
2,829
2,060
4,629
2,179
43
Net Investing Cash Flow
3,833
21
7,573
5,243
3,680
Cash Dividends Paid - Total
-
1,331
241
-
241
Issuance/Reduction of Debt, Net
1,556
67
7,393
658
367
Net Financing Cash Flow
1,556
24
7,174
637
560
Net Change in Cash
798
239
2,716
1,528
182
Free Cash Flow
2,086
1,763
201
1,427
856
Other Sources
165
-
-
-
-
Change in Capital Stock
-
1,334
-
-
-
Exchange Rate Effect
9
35
14
6
-
Other Uses
199
-
-
-
-

About Syngene International

View Profile
Address
Biocon Park , Plot 2&3, Phase-IV
Bangalore Karnataka 560099
India
Employees -
Website http://www.syngeneintl.com
Updated 09/14/2018
Syngene International Ltd. operates as a contract research organization, which provides discovery and development services for novel molecular entities. Its services include discovery chemistry, discovery biology, safety assessment, large molecule development, chemical development, formulation development, stability studies, polymer research, integrated discovery and development, and clinical development. The company was founded on November 18, 1993 and is headquartered in Bangalore, India.